FleishmanHillard

United States

When 2025 arrived, we were ready for what health needed next. To stop just communicating and start advising. To move beyond campaigns to decisions that shape health outcomes. To bring data, AI and Corporate Affairs together for real world impact. FleishmanHillard Health & Life Sciences is a 300+ strong team of specialists across New York, San Francisco, Washington, D.C. and the global FH network. In a year of volatility for pharma, biotech and MedTech, we helped clients navigate intense scrutiny, evolving expectations around equity and access and rapid scientific change. We didn't just react to events; we helped set the agenda.

We launched and sustained category-defining work in multiple myeloma, psoriasis and depression. We supported long-term partners like Johnson & Johnson, Bayer and Philips while winning $25M+ in new Health & Life Sciences business and expanding 36% of existing relationships.

At FleishmanHillard, our Health & Life Sciences practice doesn't embrace change; we drive it—by connecting one dot at a time, adapting and being relentless.